Berna Demiray

Berna Demiray currently serves as Senior Director of Global Commercial Strategy and Corporate Strategy at Soleno Therapeutics, Inc. since May 2024. Previously, Berna was Chief of Staff to the CEO at Sangamo Therapeutics, Inc. from May 2022 to January 2024, contributing to corporate strategy development for innovative cell and gene therapies. An extensive background at EY spanned nearly a decade, where Berna held positions such as Life Sciences Senior Manager and Life Sciences Strategy Consultant, focusing on business strategy, stakeholder management, and large-scale transformation in the life sciences sector. Academic credentials include a PhD in Cell Signalling Pathways from University College London and CIMA certification.